Rollover Study in Participants With Metastatic Solid Tumors Benefiting From Therapy With Sacituzumab Govitecan-hziy

Institut Jules Bordet, Brussels

CHU UCL NAMUR - Sainte Elisabeth, Namur

New York Cancer & Blood Specialists - Setauket Medical Oncology, Port Jefferson

UPMC Hillman Cancer Center, Pittsburgh

Christiana Care Health Services, Christiana Hospital, Newark

University of MD Greenebaum Comprehensive Cancer Center, Baltimore

Institut Claudius Regaud, Toulouse

Institut Bergonie, Bordeaux

Baptist Health - Miami Cancer Institute, Miami

Florida Cancer Specialists & Research Institute, Fort Myers

Illinois Cancer Specialists, Arlington Heights

University of Chicago, Chicago

Centre Leon Berard, Lyon

Oncology Consultants,P.A., Houston

The University of Texas M.D. Anderson Cancer Center, Houston

NEXT Oncology, San Antonio

Next Oncology, Austin

Rocky Mountain Cancer Center, Aurora

University of California San Francisco, San Francisco

Massachusetts General Hospital, Boston

Dana Farber Cancer Institute, Boston